Publisher: Icon Group International, Inc.
Category: Diseases & Conditions

Diseases & Conditions market research reports by Icon Group International, Inc.

(630 reports matching your criteria)
    • The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing

      The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing This study covers the world outlook for pap smear tests for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More

    • The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits

      The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits This study covers the world outlook for autoimmune disease diagnostic consumables and assay kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More

    • The 2025-2030 World Outlook for Cancer Stem Cells

      The 2025-2030 World Outlook for Cancer Stem Cells This study covers the world outlook for cancer stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Cancer Supportive Care

      The 2025-2030 World Outlook for Cancer Supportive Care This study covers the world outlook for cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Cancer Testing-Screening

      The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Cancer Diagnostics

      The 2025-2030 World Outlook for Cancer Diagnostics This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Urothelial Cancer Drugs

      The 2025-2030 World Outlook for Urothelial Cancer Drugs This study covers the world outlook for urothelial cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Crohn's Disease Drugs

      The 2025-2030 World Outlook for Crohn's Disease Drugs This study covers the world outlook for Crohn's disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Pulmonary Hypertension

      The 2025-2030 World Outlook for Pulmonary Hypertension This study covers the world outlook for pulmonary hypertension across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Ovarian Cancer Diagnostics

      The 2025-2030 World Outlook for Ovarian Cancer Diagnostics This study covers the world outlook for ovarian cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Ovarian Cancer Drugs

      The 2025-2030 World Outlook for Ovarian Cancer Drugs This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Insulin Delivery Devices

      The 2025-2030 World Outlook for Insulin Delivery Devices This study covers the world outlook for insulin delivery devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Osteoporosis Treatments

      The 2025-2030 World Outlook for Osteoporosis Treatments This study covers the world outlook for osteoporosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Artificial Pancreas Systems

      The 2025-2030 World Outlook for Artificial Pancreas Systems This study covers the world outlook for artificial pancreas systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Iron Deficiency Anemia Drugs

      The 2025-2030 World Outlook for Iron Deficiency Anemia Drugs This study covers the world outlook for iron deficiency anemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Breast Cancer Imaging Devices

      The 2025-2030 World Outlook for Breast Cancer Imaging Devices This study covers the world outlook for breast cancer imaging devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests

      The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests This study covers the world outlook for cancer diagnostics laboratory tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Proliferative Diabetic Retinopathy Treatments

      The 2025-2030 World Outlook for Proliferative Diabetic Retinopathy Treatments This study covers the world outlook for proliferative diabetic retinopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2025-2030 World Outlook for Type I Segment in Gaucher Diseases

      The 2025-2030 World Outlook for Type I Segment in Gaucher Diseases This study covers the world outlook for type i segment in gaucher diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Cancer Immunotherapies

      The 2025-2030 World Outlook for Cancer Immunotherapies This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies

      The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies This study covers the world outlook for cancer immunotherapy monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Hematologic Malignancies

      The 2025-2030 World Outlook for Hematologic Malignancies This study covers the world outlook for hematologic malignancies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Particle Therapies

      The 2025-2030 World Outlook for Particle Therapies This study covers the world outlook for particle therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Particle Treatment Devices

      The 2025-2030 World Outlook for Particle Treatment Devices This study covers the world outlook for particle treatment devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Models

      The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Models This study covers the world outlook for patient derived xenograft-PDX models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

10 11 12 13 14 15 16 17 18 19

Cookie Settings